Brinker Capital Inc. lowered its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 8.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,476 shares of the business services provider’s stock after selling 2,863 shares during the quarter. Brinker Capital Inc. owned 0.06% of Exponent worth $1,545,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in the business. Jefferies Financial Group Inc. acquired a new stake in Exponent in the 4th quarter worth approximately $1,415,000. RMB Capital Management LLC acquired a new stake in Exponent in the 4th quarter worth approximately $288,000. Geode Capital Management LLC boosted its stake in Exponent by 9.6% in the 4th quarter. Geode Capital Management LLC now owns 648,674 shares of the business services provider’s stock worth $32,893,000 after purchasing an additional 56,600 shares in the last quarter. Fort L.P. boosted its stake in Exponent by 94.4% in the 4th quarter. Fort L.P. now owns 28,729 shares of the business services provider’s stock worth $1,457,000 after purchasing an additional 13,948 shares in the last quarter. Finally, Magnus Financial Group LLC acquired a new stake in Exponent in the 4th quarter worth approximately $230,000. Institutional investors and hedge funds own 89.36% of the company’s stock.
Shares of NASDAQ EXPO opened at $57.39 on Wednesday. Exponent, Inc. has a 12 month low of $38.17 and a 12 month high of $58.29. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 45.91 and a beta of 0.47.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 22nd. Shareholders of record on Friday, March 8th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 1.12%. This is a boost from Exponent’s previous quarterly dividend of $0.13. The ex-dividend date is Thursday, March 7th. Exponent’s payout ratio is presently 51.20%.
A number of research firms recently commented on EXPO. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, December 13th. BidaskClub cut shares of Exponent from a “buy” rating to a “hold” rating in a research note on Thursday, December 6th. Zacks Investment Research cut shares of Exponent from a “buy” rating to a “hold” rating in a research note on Thursday, January 17th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 target price on shares of Exponent in a research note on Tuesday, January 15th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $56.00.
In other Exponent news, insider Harri Kytomaa sold 2,366 shares of Exponent stock in a transaction that occurred on Friday, February 22nd. The shares were sold at an average price of $56.27, for a total transaction of $133,134.82. Following the completion of the sale, the insider now directly owns 3,816 shares in the company, valued at approximately $214,726.32. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.70% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Brinker Capital Inc. Lowers Holdings in Exponent, Inc. (EXPO)” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://sportsperspectives.com/2019/03/20/brinker-capital-inc-lowers-holdings-in-exponent-inc-expo.html.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Featured Story: Compound Interest
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.